10x Genomics Цена / балансовая стоимость
Что обозначает Цена / балансовая стоимость в 10x Genomics?
Цена / балансовая стоимость 10x Genomics, Inc. является 5.40
Какое определение для Цена / балансовая стоимость?
Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Цена / балансовая стоимость компаний в Health Care сектор на NASDAQ по сравнению с 10x Genomics
Что делает 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Компании с цена / балансовая стоимость похож на 10x Genomics
- Cerner имеет Цена / балансовая стоимость из 5.39
- Plurilock Security имеет Цена / балансовая стоимость из 5.39
- Spirent Communications Plc имеет Цена / балансовая стоимость из 5.39
- Jindal Stainless (Hisar) имеет Цена / балансовая стоимость из 5.40
- Loop имеет Цена / балансовая стоимость из 5.40
- Volt Carbon Technologies Inc имеет Цена / балансовая стоимость из 5.40
- 10x Genomics имеет Цена / балансовая стоимость из 5.40
- EURO Ressources SA имеет Цена / балансовая стоимость из 5.40
- Adriatic Metals PLC имеет Цена / балансовая стоимость из 5.40
- Hoshi Resource Corp имеет Цена / балансовая стоимость из 5.40
- Varonis Systems Inc имеет Цена / балансовая стоимость из 5.41
- Antares Pharma Inc имеет Цена / балансовая стоимость из 5.41
- Altair Engineering Inc имеет Цена / балансовая стоимость из 5.41